+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Status Unknown

Age: 18Years +
All Genders
ID03197259

Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study

Led by Fatih Demirkan, MD · Updated on 2021-03-09

1000

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

CONDITIONS

Brief Title

Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Inclusion Criteria:

  • Patients diagnosed as CLL
  • 18 years or older
  • Able and willing to provide the written informed consent

Exclusion Criteria:

  • Younger than 18 years

Research Team

F

Fatih Demirkan, Prof

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here